Exploring Streptococcus Milleri in superficial suppurative lymphadenitis: a retrospective review
Australian Journal of Otolaryngology · 2025-04 · 8 · 15-15
DOI: 10.21037/ajo-24-46 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian Journal of Otolaryngology, 2025-04. Verfasst von Stephanie Soon und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Streptococcus Milleri is commonly found in the oral cavity, oropharynx and gastrointestinal tract and has been linked to pyogenic infections. Reports on the incidence of head and neck abscesses caused by Streptococcus Milleri have increased in the last few decades; however, literature remains scarce. Furthermore, Therapeutic Guidelines recommend cefalexin or flucloxacillin as first line antibiotic therapy for cervical lymphadenopathy. However, Streptococcus Milleri is most sensitive to Penicillin G . This study aims to examine the incidence of Streptococcus Milleri in superficial suppurative lymphadenitis and the implications of this on recommended antibiotic therapy.
Methods
This is a retrospective review of patients with superficial suppurative lymphadenitis in a tertiary hospital in Queensland, Australia from February 2019 to June 2024. Patient data was collected from electronic medical records on cultured microorganism, antibiotic choice, duration of therapy and complications. Inclusion criteria comprised of patients with intra-operative samples sent for microscopy, culture, and sensitivity.
Results
A total of 30 patients underwent incision and drainage of a superficial suppurative lymphadenitis between February 2019 to June 2024. This study found that Streptococcus Milleri was the most common microorganism cultured. This was cultured in nearly a quarter of patients (23.3%). Streptococcus Milleri was more common in male patients (57.1%) and patients aged 18 years old and older (71.4%). Patients with Streptococcus Milleri cultures experienced longer inpatient stays, total antibiotic durations and a higher incidence of changes to their initial intravenous (IV) antibiotic regimen based on intraoperative culture results. The odds ratio for hospital representation for Streptococcus Milleri patients was 1.1 (95% confidence interval: 0.1–12.8) with a p value of 1, suggesting no significant difference between the groups. Similarly, the odds ratios for gender (male/female) and changes in IV antibiotics were greater than 1, indicating a higher likelihood of these outcomes. However, none of these relationships were statistically significant (P>0.05).
Conclusions
The findings of this study demonstrate a need for increased awareness of Streptococcus Milleri in patients presenting with superficial suppurative lymphadenitis and provides foundational insights for future research in this area.
Zitieren
APA
Soon, S., & Placanica, T. (2025). Exploring Streptococcus Milleri in superficial suppurative lymphadenitis: a retrospective review. Australian Journal of Otolaryngology, 8, 15-15. https://doi.org/10.21037/ajo-24-46
Vancouver
Soon S, Placanica T. Exploring Streptococcus Milleri in superficial suppurative lymphadenitis: a retrospective review. Australian Journal of Otolaryngology. 2025;8:15-15. doi:10.21037/ajo-24-46
BibTeX
@article{Soon2025,
author = {Soon, Stephanie and Placanica, Thomas},
title = {Exploring Streptococcus Milleri in superficial suppurative lymphadenitis: a retrospective review},
journal = {Australian Journal of Otolaryngology},
year = {2025},
volume = {8},
pages = {15--15},
doi = {10.21037/ajo-24-46}
}
EUVIMED